Navigation Links
Study: RSV often milder than flu in older adults

MARSHFIELD, Wis., Dec. 18, 2013 /PRNewswire/ -- Respiratory Syncytial Virus (RSV) appears to cause milder illness than influenza in adults age 50 or older, according to researchers at Marshfield Clinic Research Foundation.


The study, published online in Clinical Infectious Diseases, also shows RSV is a common cause of respiratory illness in older adults and that the chance of infection increases with age.

"RSV has long been known to cause serious respiratory illness in infants, but much less is known about the illnesses RSV causes in older adults," said Dr. Edward Belongia, director of the Epidemiology Research Center at Marshfield Clinic Research Foundation (MCRF). "Knowing that adults' susceptibility to RSV increases as they age is important for health care providers and public health officials to note as they treat and monitor respiratory illnesses this season."

RSV is a common virus that causes infections of the lungs and breathing passages. The virus is thought to cause about 10 percent of winter hospitalizations for pneumonia in adults 65 and older. Most healthy people recover from RSV in one to two weeks, but for some infants, children and older adults, RSV causes serious illness. Most children have had RSV by age 2.

Study results suggest flu may cause more severe illness than RSV in older adults. That's based on two key points:

  • People with RSV delayed seeking treatment after the onset of illness more than patients with flu.
  • Fewer RSV patients were hospitalized within 30 days compared to those with flu.

Symptoms of RSV are cold-like in most instances and include congested or runny nose, dry cough, low-grade fever, sore throat and headache. In severe cases, the contagious virus causes high fever, severe cough, wheezing, rapid breathing and bluish color of the skin due to lack of oxygen.

"Influenza gets a lot of attention this time of the year and for good reason – it's a serious illness that affects thousands of people," said MCRF epidemiologist Maria Sundaram, one of the study's lead authors. "Although this study showed RSV may lead to fewer complications than flu, it still has the potential to cause serious respiratory illness, especially in older adults with weakened immune systems or other pre-existing conditions."

Further work is needed to understand why older adults are more susceptible to RSV than other groups, MCRF researchers said. For the study, scientists including Dr. Jennifer Meece, director of MCRF's Core Laboratory, studied nasal and throat swabs from patients age 50 and older recruited for influenza vaccine effectiveness studies from 2004-10. MedImmune, LLC, provided funding for this study.

Marshfield Clinic Research Foundation (MCRF), a division of Marshfield Clinic, was founded in 1959. It's the largest private medical research institute in Wisconsin. MCRF consists of research centers in clinical research, agricultural health and safety, epidemiology, human genetics, and biomedical informatics. Marshfield Clinic investigators publish extensively in peer-reviewed medical and scientific journals addressing a wide range of diseases and other health issues, including cancer, heart disease, diabetes, eye disease, neurological disease, pediatrics, radiology, women's health, agricultural safety and genetics.

The Marshfield Clinic system provides patient care, research and education with more than 50 locations in northern, central and western Wisconsin, making it one of the largest comprehensive medical systems in the United States.

SOURCE Marshfield Clinic
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Study: Latent Viruses Change Cells in the Human Body; the Study Supports the Link between Latent Viruses and Disease
2. Study: Higher Hepatitis C Infection During Acupuncture in Asian Americans; polyDNA Recommends That Doctors Prescribe Gene-Eden-VIR against HCV
3. Technical Study: Gilead Sciences Inc., Halozyme Therapeutics Inc., NPS Pharmaceuticals Inc., and InterMune Inc.
4. Technical Study: Vertex Pharma Inc., Orexigen Therapeutics Inc., MAKO Surgical Corp., and Alere Inc.
5. Study: FOLFIRINOX Followed by Chemoradiation Shows Substantial Activity in Locally Advanced Pancreatic Cancer
6. New Study: Valtrex (Valacyclovir) Side Effects Target the Brain; polyDNA Suggests a Natural Herpes Remedy
7. Study: Brain Imaging After Mild Head Injury/Concussion Can Show Lesions
8. RPCI-Led Study: FAK Inhibitor Proves Effective Against Brain Tumors in Preclinical Studies
9. Nature Materials study: Boosting heat transfer with nanoglue
10. New Study: Health Professionals Support Biotechnologys Use In Food Products And Sustainable Farming
11. Nature Materials study: Graphene invisible to water
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... ... Organization of Black Aerospace Professionals (OPBAP) has been formalized with the signing of ... team leaders met with OPBAP leaders Capt. Karl Minter and Capt. Albert Glenn ...
(Date:11/24/2015)... Malaysia , Nov. 24, 2015  Asia-Pacific ... contract research organisation (CRO) market. The trend of ... in lower margins but higher volume share for ... capacity and scale, however, margins in the CRO ... Organisation (CRO) Market ( ), finds ...
(Date:11/24/2015)... 2015 /CNW/ - iCo Therapeutics ("iCo" or "the Company") ... for the quarter ended September 30, 2015. Amounts, ... and presented under International Financial Reporting Standards ("IFRS"). ... said Andrew Rae , President & CEO ... not only value enriching for this clinical program, ...
(Date:11/24/2015)... Inc., a worldwide provider of clinical research services headquartered in ... has set a new quarterly earnings record in Q3 of 2015.  ... Q3 of 2014 to Q3 of 2015.   ... the establishment of an Asia-Pacific office to ... and Mexico , with the establishment ...
Breaking Biology Technology:
(Date:11/10/2015)... Nov. 10, 2015 About ... that helps to identify and verify the identity ... considered as the secure and accurate method of ... a particular individual because each individual,s signature is ... especially when dynamic signature of an individual is ...
(Date:11/4/2015)... New York , November 4, 2015 ... to a new market report published by Transparency Market ... Share, Growth, Trends and Forecast 2015 - 2022", the global ... of US$ 30.3 bn by 2022. The market is ... the forecast period from 2015 to 2022. Rising security ...
(Date:10/29/2015)... , Oct. 29, 2015  The J. Craig ... report titled, "DNA Synthesis and Biosecurity: Lessons Learned and ... Department of Health and Human Services guidance for synthetic ... 2010. --> --> ... also has the potential to pose unique biosecurity threats. ...
Breaking Biology News(10 mins):